Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection

Huawei Xia1, Zeming Zhang1, Fuping You1

  • 1Department of Systems Biomedicine, Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.

Viruses
|December 28, 2021
PubMed

Insights

Murine hepatitis virus-A59 (MHV-A59) infection induces ferroptosis, a cell death pathway. Inhibiting ferroptosis protects against MHV-A59-induced lung inflammation and viral spread, suggesting a new therapeutic target.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Murine hepatitis virus strain A59 (MHV-A59) causes cell death, including pyroptosis, apoptosis, and necroptosis.
  • The role of ferroptosis, a distinct form of lytic cell death, in MHV-A59 pathogenicity remained unexplored.

Purpose of the Study:

  • To investigate the involvement of ferroptosis in MHV-A59 infection.
  • To explore ferroptosis-related gene expression changes during MHV-A59 infection.
  • To evaluate the therapeutic potential of targeting ferroptosis against MHV-A59.

Main Methods:

  • Utilized primary murine macrophages and a C57BL/6 mice intranasal infection model.
  • Administered ferroptosis inhibitors (e.g., liproxstatin-1, Triacsin C) and performed RNA-sequencing.
  • Investigated the role of Toll-like receptor 4 (TLR4) and NF-kB signaling pathways.

Main Results:

  • Ferroptosis inhibition reduced viral propagation, inflammatory cytokine release, and syncytia formation in vitro.
  • In vivo liproxstatin-1 administration ameliorated lung inflammation and tissue injury in infected mice.
  • MHV-A59 infection upregulated acyl-CoA synthetase long-chain family member 1 (ACSL1), a ferroptosis inducer, in a NF-kB-dependent, TLR4-independent manner.
  • ACSL1 inhibition suppressed MHV-A59-induced syncytia formation and viral propagation.

Conclusions:

  • Ferroptosis plays a significant role in MHV-A59 pathogenesis.
  • Inhibition of ferroptosis offers a protective effect against MHV-A59 infection and associated hyper-inflammation.
  • Targeting ferroptosis, particularly ACSL1, presents a promising therapeutic strategy for coronavirus infections.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...